PCVX is currently covered by 1 analysts with average potential upside of $22.43 (87.39%) backed by 1 price targets and 3 ratings. Documented since 07-Jul-2020. Analyst's average stock valuation to be materialised ratio is 66.67% with an average time for price targets to be met of 202.5 days.
Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 08-Nov-2022.
Highest price target for PCVX is 45, Lowest price target is 26, average price target is 35.5.
Currently, out of the existing stock ratings of PCVX - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
70
$33.73 (93.00%)
55
4 months 23 days ago
1/3 (33.33%)
$26.86 (86.70%)
77
Buy
37
$-9.17 (-19.86%)
44
7 months 19 days ago
2/2 (100%)
$17.99 (88.08%)
328
What is PCVX(Vaxcyte Inc.) average time for price targets to be met?
Which analyst has the current highest performing score on PCVX(Vaxcyte Inc.) with a proven track record?
